
The Trump administration is terminating 22 contracts focused on developing mRNA vaccines and winding down additional federal investments in mRNA technology, Health and Human Services Secretary Robert F. Kennedy Jr. announced Tuesday. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading.
Main Idea: Robert F. Kennedy Jr. and the Department of Health and Human Services are cutting nearly $500 million in mRNA vaccine contracts, a move that scientists say could hurt future pandemic readiness.
Key Points:
HHS and BARDA cutting mRNA contracts may slow vaccine research and leave Americans less prepared for the next flu or pandemic.
Federal money may shift to other vaccine approaches if those prove safer or more durable.
Rate how each entity in this article affected the American people.
The agency taking the central action by terminating and restructuring mRNA-related contracts.
Central decision-maker who announced the contract cuts and is the main focus of the article.
HHS program whose BARDA-funded contracts are being terminated; a major actor in the funding cuts.
Named biotechnology company directly affected by the canceled/restructured federal collaboration.
Named company that says it was directed to stop work on a therapeutic as part of the cuts.
Cited for vaccine-safety and lives-saved estimates used to contextualize the debate.
Kennedy-founded anti-vaccine group that publicly applauded the defunding decision.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentNamed infectious disease specialist quoted rebutting Kennedy’s claims about mRNA vaccines.
Named vaccine expert quoted criticizing the policy decision as not science-based.
Former BARDA director quoted criticizing the move and explaining its public-health implications.
Named research institution affected by the termination of an mRNA-related award.
Referenced as another consulted federal agency in Kennedy’s announcement.